Royce & Associates’s Apyx Medical APYX Stock Holding History

Royce & Associates’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.49M	Sell	2,439,703 -85,764	-3%	-$193K	0.06%	437
2025 Q1	$3.46M	Sell	2,525,467 -89,902	-3%	-$123K	0.04%	502
2024 Q4	$4.13M	Buy	2,615,369 +32,879	+1%	+$51.9K	0.04%	523
2024 Q3	$3.2M	Buy	2,582,490 +85,267	+3%	+$106K	0.03%	556
2024 Q2	$3.35M	Buy	2,497,223 +60,564	+2%	+$81.2K	0.03%	548
2024 Q1	$3.31M	Buy	2,436,659 +277,759	+13%	+$378K	0.03%	561
2023 Q4	$5.66M	Buy	2,158,900 +149,300	+7%	+$391K	0.05%	469
2023 Q3	$6.43M	Buy	2,009,600 +406,624	+25%	+$1.3M	0.07%	415
2023 Q2	$8.06M	Buy	1,602,976 +145,759	+10%	+$733K	0.08%	366
2023 Q1	$4.2M	Buy	1,457,217 +658,749	+83%	+$1.9M	0.04%	521
2022 Q4	$1.87M	Sell	798,468 -85,800	-10%	-$201K	0.02%	657
2022 Q3	$3.97M	Buy	884,268 +415,000	+88%	+$1.86M	0.04%	494
2022 Q2	$2.75M	Buy	469,268 +6,800	+1%	+$39.8K	0.03%	615
2022 Q1	$3.02M	Sell	462,468 -11,600	-2%	-$75.8K	0.03%	651
2021 Q4	$6.08M	Sell	474,068 -69,732	-13%	-$894K	0.05%	517
2021 Q3	$7.53M	Sell	543,800 -15,000	-3%	-$208K	0.06%	489
2021 Q2	$5.76M	Hold	558,800	–	–	0.04%	576
2021 Q1	$5.4M	Hold	558,800	–	–	0.04%	584
2020 Q4	$4.02M	Hold	558,800	–	–	0.03%	593
2020 Q3	$2.63M	Buy	558,800 +204,900	+58%	+$965K	0.03%	630
2020 Q2	$1.96M	Sell	353,900 -37,131	-9%	-$206K	0.02%	669
2020 Q1	$1.4M	Sell	391,031 -120,784	-24%	-$434K	0.02%	677
2019 Q4	$4.33M	Buy	511,815 +45,900	+10%	+$388K	0.04%	523
2019 Q3	$3.15M	Buy	465,915 +113,400	+32%	+$768K	0.03%	599
2019 Q2	$2.37M	Sell	352,515 -402,900	-53%	-$2.71M	0.02%	686
2019 Q1	$4.77M	Buy	755,415 +60,415	+9%	+$381K	0.04%	514
2018 Q4	$4.5M	Sell	695,000 -15,000	-2%	-$97.2K	0.04%	528
2018 Q3	$5.04M	Hold	710,000	–	–	0.03%	597
2018 Q2	$3.09M	Buy	710,000 +23,400	+3%	+$102K	0.02%	731
2018 Q1	$2.04M	Buy	686,600 +28,600	+4%	+$84.9K	0.01%	848
2017 Q4	$1.71M	Buy	+658,000	New	+$1.71M	0.01%	873